Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell therapy for autoimmune diseases.

Francesco Dazzi1, Jacob M van Laar, Andrew Cope

  • 1Stem Cell Biology Section, Kennedy Institute of Rheumatology, Imperial College Faculty of Medicine, London, UK. f.dazzi@imperial.ac.uk

Arthritis Research & Therapy
|March 21, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Individualised treatment effect prediction: the benefit of initial biological treatment in early rheumatoid arthritis.

EULAR rheumatology open·2026
Same author

Five years of the Digital Rheumatology Network: insights and future directions.

EULAR rheumatology open·2026
Same author

Recent developments in the use of biomarkers as diagnostic tools in patients with systemic lupus erythematosus: a narrative review.

EULAR rheumatology open·2026
Same author

Psychosocial and behavioral correlates of persistent pain post disease-modifying treatment change in rheumatoid arthritis: a 12-month cohort study.

Advances in rheumatology (London, England)·2026
Same author

A composite biomarker score to predict modified Rodnan skin score in systemic sclerosis: insight from autologous stem cell transplantation international scleroderma trial.

Arthritis research & therapy·2025
Same author

MSC Manufacture.

Advances in experimental medicine and biology·2025

Cell therapy, including autologous hematopoietic stem cell transplantation (HSCT), offers a curative option for severe autoimmune diseases. This approach resets abnormal immune regulation, paving the way for new cell-based treatments.

Area of Science:

  • Immunology
  • Cell Therapy
  • Autoimmune Diseases

Background:

  • Bone marrow transplantation, a form of cell therapy, is now successfully used for autoimmune diseases.
  • Autologous hematopoietic stem cell transplantation (HSCT) is a curative option for severe autoimmune conditions like scleroderma, multiple sclerosis, and lupus.
  • Advances in conditioning regimens have significantly reduced transplant-related mortality, making HSCT a safer treatment option.

Purpose of the Study:

  • To explore the therapeutic potential of cell therapy in autoimmune diseases.
  • To understand the mechanisms behind HSCT efficacy beyond immunosuppression.
  • To identify novel cell-based strategies for autoimmune disease treatment.

Main Methods:

  • Review of existing literature on cell therapy and HSCT for autoimmune diseases.

Related Experiment Videos

  • Analysis of the role of immune-resetting mechanisms in HSCT.
  • Identification of key immunosuppressive cells and their properties.

    • Main Results:

    • HSCT has become a safe and effective treatment for severe autoimmune diseases.
    • The efficacy of HSCT is attributed to resetting abnormal immune regulation, not just immunosuppression.
    • Regulatory T cells and mesenchymal stem cells show promise for autoimmune disease therapy.

    Conclusions:

    • Cell therapy, particularly HSCT, is a viable and evolving treatment for autoimmune diseases.
    • Understanding immune-resetting mechanisms opens new avenues for targeted cell therapies.
    • Further preclinical investigation of regulatory T cells and mesenchymal stem cells is warranted for clinical application.